Accessibility Menu
 
Cassava Sciences logo

Cassava Sciences

(NASDAQ) SAVA

Current Price$1.72
Market Cap$83.57M
Since IPO (2000)-98%
5 Year-95%
1 Year+20%
1 Month-9%

Cassava Sciences Financials at a Glance

Market Cap

$83.57M

Revenue (TTM)

$0.00

Net Income (TTM)

$90.97M

EPS (TTM)

$-1.88

P/E Ratio

-0.92

Dividend

$0.00

Beta (Volatility)

1.19 (Average)

Price

$1.72

Volume

463,062

Open

$1.75

Previous Close

$1.73

Daily Range

$1.69 - $1.76

52-Week Range

$1.37 - $4.98

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cassava Sciences

Industry

Pharmaceuticals

Employees

20

CEO

Richard Jon Barry

Headquarters

Austin, TX 78731, US

SAVA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-83%

Return on Capital

-1%

Return on Assets

-77%

Earnings Yield

-1.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$83.57M

Shares Outstanding

48.31M

Volume

463.06K

Short Interest

0.00%

Avg. Volume

627.92K

Financials (TTM)

Gross Profit

$936.00K

Operating Income

$95.39M

EBITDA

$94.45M

Operating Cash Flow

$32.25M

Capital Expenditure

$581.00K

Free Cash Flow

$32.83M

Cash & ST Invst.

$95.50M

Total Debt

$0.00

Cassava Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$18.98M

+192.5%

Gross Margin

0.00%

N/A

Market Cap

$83.57M

N/A

Market Cap/Employee

$2.79M

N/A

Employees

30

N/A

Net Income

$12.54M

+54.6%

EBITDA

$48.61M

-151.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$95.50M

-25.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-76.86%

N/A

Return on Invested Capital

-1.28%

N/A

Free Cash Flow

$10.25M

+83.3%

Operating Cash Flow

$9.75M

+84.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RANIRani Therapeutics Holdings, Inc.
$0.96+4.07%
PEPGPepGen Inc.
$1.70+1.80%
CRDFCardiff Oncology, Inc.
$1.80+6.51%
MOLNMolecular Partners AG
$4.21+0.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
EFOIEnergy Focus
$6.49+2.11%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.90+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.59+0.04%
IBITiShares Bitcoin Trust
$43.94+0.03%

Questions About SAVA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.